{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:12Z","timestamp":1793608032018,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["175288"],"award-info":[{"award-number":["175288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129110","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:18:53Z","timestamp":1788491933000},"page":"129110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mucosal adjuvant activity of a PAR-2\u2013activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime\u2013boost influenza vaccination model"],"prefix":"10.1016","volume":"92","author":[{"given":"Claudia A.","family":"Kornuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harissios","family":"Vliagoftis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129110_bb0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza virus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00040-22","article-title":"Antiviral approaches against influenza virus","volume":"36","author":"Kumari","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.129110_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126408","article-title":"Advancing influenza vaccines: a review of next-generation candidates and their potential for global health impact","volume":"42","author":"Taaffe","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129110_bb0020","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2017.0141","article-title":"Influenza virus: dealing with a drifting and shifting pathogen","volume":"31","author":"Kim","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70056","article-title":"Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.vaccine.2026.129110_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2026.129110_bb0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist\u00ae; Fluenz\u2122)","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2026.129110_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12080936","article-title":"Vaccines for respiratory viruses\u2014COVID and beyond","volume":"12","author":"Rajanala","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129110_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/07853890.2017.1407035","article-title":"Understanding modern-day vaccines: what you need to know","volume":"50","author":"Vetter","year":"2018","journal-title":"Ann Med"},{"key":"10.1016\/j.vaccine.2026.129110_bb0050","doi-asserted-by":"crossref","unstructured":"Kawabata A. PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2002;2002:1\u201317. doi:https:\/\/doi.org\/10.1017\/s1462399402004799.","DOI":"10.1017\/S1462399402004799"},{"key":"10.1016\/j.vaccine.2026.129110_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-024-00338-1","article-title":"Par2-mediated responses in inflammation and regeneration: choosing between repair and damage","volume":"44","author":"Reches","year":"2024","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.vaccine.2026.129110_bb0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4049\/jimmunol.1800915","article-title":"Protease-activated receptor 2 agonist as adjuvant: augmenting development of protective memory CD8 T cell responses induced by influenza virosomes","volume":"203","author":"Zhou","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0065","series-title":"Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes)","author":"Bron","year":"1993"},{"key":"10.1016\/j.vaccine.2026.129110_bb0070","series-title":"Methods Mol. Biol.","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-7896-0_6","article-title":"Isolation and purification of epithelial and endothelial cells from mouse lung","volume":"1799","author":"Nakano","year":"2018"},{"key":"10.1016\/j.vaccine.2026.129110_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2006.01.022","article-title":"Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB\/cAnNCrl mice","volume":"312","author":"Van den Broeck","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2026.129110_bb0080","article-title":"A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129110_bb0085","first-page":"1","article-title":"Age-related loss of CD62L impairs lymph node CD4 T cell mobiliza-tion","volume":"1","author":"Chiu","year":"2007","journal-title":"Open Longev Sci"},{"key":"10.1016\/j.vaccine.2026.129110_bb0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.1402975","article-title":"Airway-resident memory CD8 T cells provide antigen-specific protection against respiratory virus challenge through rapid IFN-\u03b3 production","volume":"195","author":"McMaster","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-00912-1","article-title":"Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine","volume":"9","author":"Bissett","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129110_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14101983","article-title":"Development of nasal vaccines and the associated challenges","volume":"14","author":"Nian","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.129110_bb0110","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.179.5.2910","article-title":"Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway","volume":"179","author":"Ebeling","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0115","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129110_bb0120","article-title":"Dendritic cell-based vaccines recruit neutrophils to the local draining lymph nodes to prime natural killer cell responses","volume":"12","author":"Chan","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2026.129110_bb0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41551-024-01209-3","article-title":"Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination","volume":"8","author":"Najibi","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.vaccine.2026.129110_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107679","article-title":"Targeting lymph node niches enhances type 1 immune responses to immunization","volume":"31","author":"Lian","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.129110_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling timing and location in vaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2026.129110_bb0140","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.4049\/jimmunol.1100987","article-title":"Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells","volume":"187","author":"Ho","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129110_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.129110_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180667","article-title":"Preservation of naive-phenotype CD4+ T cells after vaccination contributes to durable immunity","volume":"9","author":"Pan","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2026.129110_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2005.04.010","article-title":"Understanding the generation and function of memory T cell subsets","volume":"17","author":"Lanzavecchia","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68662","article-title":"Protective function and durability of mouse lymph node-resident memory CD8+ T cells","volume":"10","author":"Anthony","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2026.129110_bb0175","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200218","article-title":"Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity","volume":"218","author":"Paik","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.129110_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41385-019-0224-7","article-title":"Pulmonary monocytes interact with effector T cells in the lung tissue to drive TRM differentiation following viral infection","volume":"13","author":"Dunbar","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1901046","article-title":"Monocyte-derived cells in tissue-resident memory T cell formation","volume":"204","author":"Chu","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0190","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2019.06.087","article-title":"Monocytes acquire the ability to prime tissue-resident T cells via IL-10-mediated TGF-\u03b2 release","volume":"28","author":"Thompson","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.129110_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/v15020301","article-title":"Differential cellular sensing of fusion from within and fusion from without during virus infection","volume":"15","author":"Hare","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.129110_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2009.03144.x","article-title":"Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo","volume":"129","author":"Ramelli","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.129110_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001925","article-title":"The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia","volume":"4","author":"Liu","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.vaccine.2026.129110_bb0210","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.cell.2024.08.009","article-title":"Divergent sensory pathways of sneezing and coughing","volume":"187","author":"Jiang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.129110_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3615","article-title":"Targeting proteinase-activated receptors: therapeutic potential and challenges","volume":"11","author":"Ramachandran","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.129110_bb0220","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2026.129110_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48365-1","article-title":"Platelet-activating factor and protease-activated receptor 2 cooperate to promote neutrophil recruitment and lung inflammation through nuclear factor-kappa B transactivation","volume":"13","author":"Silva","year":"2023","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:39:04Z","timestamp":1793605144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0264410X26009199"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129110","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal adjuvant activity of a PAR-2\u2013activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime\u2013boost influenza vaccination model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129110"}}